Boehringer May Face More Sanctions In Pradaxa MDL

By Greg Ryan (December 19, 2013, 6:15 PM EST) -- A week after hitting Boehringer Ingelheim International GmbH with a nearly $1 million penalty for discovery abuses, an Illinois federal judge ruled Wednesday that the drugmaker may be slapped with even more sanctions in multidistrict litigation over its blood thinner Pradaxa....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!